Show simple item record

dc.contributor.authorLópez-Muñoz, F.
dc.contributor.authorGarcía-García, P.
dc.contributor.authorÁlamo González, C
dc.date.accessioned2018-06-26T14:17:28Z
dc.date.available2018-06-26T14:17:28Z
dc.date.issued2014
dc.identifier.citationLópez-Muñoz, Francisco & Álamo, Cecilio & García-García, Pilar. (2014). Treatment of Depression in Elderly: The Challenge to Success. International Journal of Clinical Psychiatry and Mental Health. 2. 77-88. 10.12970/2310-8231.2014.02.01.8.es
dc.identifier.issn2310-8231
dc.identifier.urihttp://hdl.handle.net/20.500.12020/762
dc.description.abstractDepression in the elderly is a major challenge to current Psychiatry and a major mental health problem for several reasons, including its clinical atypicity (hampering a correct diagnosis), its greater severity and risk of suicide. The success of drug treatment will depend on a suitable assessment of the risk-benefit balance. In this review, we will address the antidepressants with a favorable side effect profile, because the elderly have a higher sensitivity to them. Antidepressant treatment in the elderly has a number of peculiarities: it should start with lower doses than those recommended for adults, it is preferable to the use of antidepressants without anticholinergic and sedative effects, to prevent cognitive impairment and risk of cardiotoxicity; it should evaluate possible interactions with other drugs, since the elderly are usually polymedicated patients with different somatic comorbidities; if antidepressant response is obtained, the drug should be kept for long periods, even for lifetime. There is a wide arsenal of antidepressant drugs with mechanisms of action focused on enhancing monoaminergic transmission. An alternative to these classical mechanisms of action is given by agomelatine, a melatoninergic agonist drug. In this paper, we discuss the pharmacodynamic and pharmacokinetic profiles of these agents that may have an influence on the efficacy, tolerability and safety of treatment in the elderly. The use of antidepressants in the elderly should be performed only when necessary, but age should not deprive the patients of medication to improve their health and quality of life.es
dc.language.isoenes
dc.publisherSynergy Publisherses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleTreatment of Depression in Elderly: The Challenge to Successes
dc.typearticlees
dc.identifier.doi10.12970/2310-8231.2014.02.01.8
dc.issue.number1es
dc.journal.titleInternational Journal of Clinical Psychiatry and Mental Healthes
dc.page.initial77es
dc.page.final88es
dc.rights.accessRightsopenAccesses
dc.subject.areaPsicologíaes
dc.subject.keywordDepressiones
dc.subject.keywordElderlyes
dc.subject.keywordTreatmentes
dc.subject.keywordDrug therapyes
dc.subject.unesco61 Psicologíaes
dc.volume.number2es


Files in this item

File/sSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional